Oncodesign Precision Medicine
ALOPM.PA
#9650
Rank
โ‚น1.71 B
Marketcap
โ‚น90.09
Share price
-1.94%
Change (1 day)
-55.12%
Change (1 year)

Revenue for Oncodesign Precision Medicine (ALOPM.PA)

Revenue in 2023: โ‚น99.98 Million

According to Oncodesign Precision Medicine's latest financial reports the company's current revenue (TTM ) is โ‚น99.98 Million. In 2023 the company made a revenue of โ‚น99.98 Million a decrease over the revenue in the year 2022 that were of โ‚น0.72 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Oncodesign Precision Medicine from 2020 to 2023

Annual revenue

Year Revenue Change
2023โ‚น99.98 M-86.16%
2022โ‚น0.72 B97.32%
2021โ‚น0.36 B-20.02%
2020โ‚น0.45 B